Inhibitors of poly (ADP‐ribose) synthetase reduce renal ischemia‐reperfusion injury in the anesthetized rat in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibitors of poly (ADP‐ribose) synthetase reduce renal ischemia‐reperfusion injury in the anesthetized rat in vivo

Published:2000-04 Issue:5 Volume:14 Page:641-651
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Chatterjee Prabal K.¹,Zacharowski Kai¹,Cuzzocrea Salvatore²,Otto Mike³,Thiemermann Christoph¹

Affiliation:

1. The William Harvey Research InstituteSt. Bartholomew's and the Royal London School of Medicine and Dentistry London EC1M 6BQ U.K.

2. Institute of PharmacologyUniversity of Messina Messina 98123 Italy

3. Institute of PathologyUniversity of Mainz Mainz D‐55101 Germany

Funder

Deutsche Gesellschaft für Kardiologie-Herz und Kreislaufforschung.

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fasebj.14.5.641

Reference42 articles.

1. Acute Renal Failure

2. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury

3. Renal ischaemia-reperfusion injury

4. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues.

5. The cell biology of reperfusion injury in the kidney;Paller M. S.;J. Invest. Med.,1994

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovations and Emerging Therapies to Combat Renal Cell Damage: NAD+ As a Drug Target;Antioxidants & Redox Signaling;2021-12-10

2. PARP inhibitors and the Kidney;Journal of Onco-Nephrology;2021-01-11

3. Poly (ADP-Ribose) Polymerase Inhibitor Treatment as a Novel Therapy Attenuating Renal Ischemia-Reperfusion Injury;Frontiers in Immunology;2020-10-14

4. Notoginsenoside R1 Suppresses Inflammatory Signaling and Rescue Renal Ischemia-reperfusion Injury in Experimental Rats;Medical Science Monitor;2020-01-26

5. Salvianolic acid A ameliorates renal ischemia/reperfusion injury by activating Akt/mTOR/4EBP1 signaling pathway;American Journal of Physiology-Renal Physiology;2018-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3